Erik L. Zeger

Publications

• Combination CBD/THC in the management of chemotherapy-induced peripheral neuropathy: a randomized double blind controlled trial. Weiss M, Giaddui M, Kjelstrom S, … Burrell J, Diguilio K, Bidas G, Erebor E, Meske S, Saeed L, Windawi S, Ruiz KA, Ghaneie A, Hibbs J, Marks J, Holtz D, Ali Z, Shevade A, Sabol J, Ciocca R, Zeger E, Gilman P, Larson S, et al. Front. Oncol., Sec. Breast Cancer; 2025;15. https://doi.org/10.3389/fonc.2025.1590168
• Primary splenic angiosarcoma presenting as thrombocytopenia. Telvizian T, May AC, Agyei O, Zeger E. BMJ Case Rep. 2025 May 8;18(5):e262536. doi: 10.1136/bcr-2024-26253
• Preliminary evaluation of a predictive blood assay to identify patients at high risk of chemotherapy-induced nausea. Kutner T, Kunkel E, Wang Y, George K, Zeger EL, Ali ZA, Prendergast GC, Gilman PB, Wallon UM. Support Care Cancer. 2017;25(2):581-7.
• Long-term outcomes by a transanal approach to total mesorectal excision for rectal cancer. Marks JH, Myers EA, Zeger EL, Denittis AS, Gummadi M, Marks GJ. Surg Endosc. 2017;31(12):5248-57.